Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC : a Pilot Study

NCT03716388 is registered in ClinicalTrials.gov with Dayanand Medical College and Hospital as lead sponsor.

NCT NCT03716388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03716388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC : a Pilot Study
Lead sponsor
Dayanand Medical College and Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
December 1, 2018
Completion date
December 1, 2019
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis chronic mild, ulcerative colitis chronic moderate